KINGSEY FALLS, QC, Feb. 23, 2012 /CNW Telbec/ - Cascades Inc. (TSX:
CAS), a leader in the recovery and manufacturing of green packaging and
tissue paper products, announces its unaudited financial results for
the three-month period and the fiscal year ended December 31, 2011.
(All amounts in this press release are in Canadian dollars unless
otherwise indicated)
Fiscal Year 2011 Strategic Highlights
- Modernization measures:
- Construction kick-off for the new, state-of-the-art, Greenpac
containerboard mill located in Niagara Falls (New York).
- Start-up of a new Atmos tissue machine to produce Premium and Ultra
quality tissue papers.
- Modernization of the equipment at the Kingsey Falls moulded pulp mill,
the Breakeyville and Auburn deink pulp mills, and the Winnipeg and
Cobourg folding carton plants.
- Restructuration measures:
- Divestiture of Dopaco for US$395 million, the Avot-Vallée white-top
linerboard plant and the Versailles and Hebron boxboard facilities.
- Consolidation of corrugated box operations in New England.
- Closure of the Burnaby containerboard facility, the Leominster and Le
Gardeur corrugated box facilities and of the East-Angus pulp mill.
- Capital optimization measures:
- Acquisition of Papersource, a leading tissue paper converter.
- Increase of our interest in Reno De Medici ("RdM") to close to 45%, the
second largest European producer of coated recycled boxboard.
- 2.1 million shares redeemed (2.1% of shares outstanding) at an average
price of $5.22.
Fiscal year highlights
- Total sales increased by 14 % compared to 2010 (including the impact of
acquisitions and divestitures).
- Total shipments up 15 % compared to 2010 (including the impact of
acquisitions and divestitures).
- Net earnings per share including specific items of $1.03 compared to
$0.43 in 2010. Net loss per share excluding specific items of $0.14 compared to net
earnings of $0.83 in 2010.
- Operating income before depreciation and amortization (EBITDA) excluding
specific items of $229 million compared to $310 million in 2010.
- Net debt increased by 6% to $1.485 billion, including $156 million of
non-recourse debt. Availability of $460 million under our revolving
credit facility.
- Appointment of Mario Plourde as Chief Operating Officer.
Fourth quarter highlights
- Net earnings per share including specific items of $0.05 compared to a net loss of $0.21 in the previous quarter and a
net loss of $0.12 in the corresponding period of last year. Net loss per share excluding specific items of $0.04 compared to a net
loss of $0.02 in the previous quarter and net earnings of $0.17 in the
same period of last year.
- EBITDA excluding specific items of $51 million compared to $79 million
in Q3 2011 and $72 million in Q4 2010.
- Net debt increased by $115 million compared to previous quarter.
Financial Summary
| Selected consolidated information |
|
|
|
|
|
|
|
(in millions of Canadian dollars, except amounts per share)
| 2011 |
2010
|
| Q4/2011 |
Q4/2010
|
Q3/2011
|
|
|
|
Sales
| 3,625 |
3,182
|
| 913 |
783
|
947
|
| Excluding specific items 1 |
|
|
Operating income before depreciation and amortization (OIBD or EBITDA)
| 229 |
310
|
| 51 |
72
|
79
|
|
|
Operating income
| 49 |
155
|
| - |
34
|
33
|
|
|
Net earnings (loss)
| (14) |
80
|
| (4) |
17
|
(2)
|
|
|
|
per common share
| $(0.14) |
$0.83
|
| $(0.04) |
$0.17
|
$(0.02)
|
|
|
Cash flow from operations (adjusted)
| 133 |
197
|
| 40 |
41
|
61
|
| As reported |
|
Operating income before depreciation and amortization (OIBD or EBITDA) 1 | 188 |
258
|
| 37 |
45
|
53
|
|
Operating income (loss)
| 8 |
103
|
| (14) |
7
|
7
|
|
Net earnings (loss)
| 99 |
41
|
| 5 |
(12)
|
(20)
|
|
|
|
per common share
| $1.03 |
$0.43
|
| $0.05 |
$(0.12)
|
$(0.21)
|
|
Cash flow from operations (adjusted) 1 | 126 |
193
|
| 35 |
41
|
60
|
Note 1 - see the supplemental information on non-IFRS measures.
|
Commenting on the annual and fourth quarter results, Mr. Alain Lemaire,
President and Chief Executive Officer stated:
"After two quarters of improvements, 2011 has ended on a disappointing
note. First, the decline in the cost of recycled fibre witnessed at the
end of the year only began to impact results in the second half of the
quarter. Then, the important increase of the cost of many of our inputs
and the strength of the Canadian dollar had a significant impact on our
profit margins and our capacity to generate cash flows. Two other
factors also influenced the fourth quarter performance. Seasonality
inherent to this quarter and softer demand experienced throughout the
industry have resulted in lower shipments. Also, lower operational
efficiency at certain of our production units has contributed to higher
production costs and lower profitability.
Despite these unfavourable conditions, we continue to focus on what we
can influence and have achieved great successes in 2011 such as the
orderly progression of our Greenpac project, the start-up of the new
Atmos machine in Candiac, the progressive implementation of our ERP
system and performance improvements achieved at certain of our
facilities without major investments. The past year was the opportunity
to fine tune the execution of our strategic plan. We have demonstrated
in the recent past that we can make difficult decisions to improve our
operational and financial performance and we will continue to do so in
order to fully profit from the impacts of more favourable market
conditions when they occur."
Results analysis for the three-month period ended December 31, 2011
(compared to the previous year)
In comparison with the same period last year, sales rose by 17% to $913
million resulting from higher selling prices, the net contribution of
business acquisitions over divestitures and the full consolidation of
the results of RdM since Q2 2011.
The operating income excluding specific items was nil compared to $34
million in Q4 2010. Higher selling prices and the contribution of
business acquisitions were more than offset by the negative impacts of
lower shipments and higher raw material costs. On a segmented basis,
our tissue and European boxboard segments posted better results while
our containerboard and specialty products segments experienced weaker
profitability. When including specific items, the operating loss
amounted to $14 million in comparison to an operating income of $7
million in the same period of last year.
In the fourth quarter of 2011, these specific items impacted our
operating income and/or net earnings (before tax):
-
A reduction of net asset value of $44 million (operating income and net
earnings);
-
Closure and restructuration costs of $3 million (operating income and
net earnings);
-
Unrealized loss of $1 million on financial instruments (operating income
and net earnings);
-
Net gain of $34 million mainly related to the Papersource transaction
(operating income and net earnings);
-
Foreign exchange gain on long-term debt and financial instruments of $9
million (net earnings);
-
Other specific items increasing net earnings by $3 million.
For further details, see the two following tables on IFRS and non-IFRS
measures reconciliation.
Net loss excluding specific items amounted to $4 million ($0.04 per
share) in the fourth quarter of 2011 compared to net earnings of $17
million ($0.17 per share) for the same period of last year. Financing
expenses were slightly lower than in Q4 2010 while the recovery of
income taxes was significantly higher. Including specific items, net
earnings were $5 million ($0.05 per share) compared to a net loss of
$12 million ($0.12 per share) for the same quarter in 2010.
Results analysis for the three-month period ended December 31, 2011
(compared to the previous quarter)
In comparison to the previous quarter, sales decreased by 3.5% due to a
6% decrease in shipments. The favourable impacts of lower raw material
prices have been offset by lower shipments.
We incurred important F/X gains on working capital items and cash flow
management related to the sale of Dopaco during the third quarter of
2011 which explains the $21 million variance in EBITDA with the current
quarter.
Results analysis for the fiscal year ended December 31, 2011
In comparison to last year, sales increased by 14% to $3.6 billion
reflecting higher selling prices, the net contribution of business
acquisitions over divestitures and the full consolidation of the
results of RdM since Q2 2011. These factors were partly offset by the
negative impact of a stronger Canadian dollar.
Despite higher selling prices in most of our business segments and the
net contribution from acquisitions, the operating income from
continuing operations excluding specific items decreased to $49 million
compared to $155 million last year mainly as a result of the higher
cost for raw material, energy, chemical products and transportation as
well as by lower shipments. In addition, profitability suffered from
lower selling prices in Canadian dollar and a 17-day business
interruption at one of our tissue mill due to a flood which resulted in
a $4 million financial impact. Operating income from continuing
operations including specific items decreased by $95 million to $8
million.
In 2011, the net loss excluding specific items amounted to $14 million
($0.14 per share) compared to net earnings of $80 million ($0.83 per
share) last year. Including specific items, net earnings reached $99
million ($1.03 per share) compared to $41 million ($0.43 per share) in
2010.
Near-term outlook
Mr. Alain Lemaire added: "Entering 2012, economic indicators are
positive in North America and point to an unstable environment in
Europe. Demand for our products remains volatile but we should improve
our performance in comparison to the same period last year. In
particular, we should benefit from the full consolidation of Reno de
Medici and Papersource during the first quarter of 2012.
We expect to continue to face challenges as it relates to the volatility
of raw material costs and the value of the Canadian dollar but we
believe there are reasons for optimism for 2012 and future years.
Indeed, since the later part of 2011, we have witnessed more favourable
market conditions. From a strategic perspective, our plan still stands:
modernize, restructure, optimize and innovate. We expect to begin
benefiting from decisions taken as part of our strategic plan since the
beginning of the year, particularly with respect to the acquisition of
Papersource and the consolidation of some of our operational centers.
To execute our strategy, we plan to invest to improve our operational
performance. However we will deploy our capital in a prudent and
gradual way to equip Cascades with a portfolio of assets that are
competitive from a manufacturing cost and product offering perspective
while maintaining an acceptable level of debt. We wish to maintain our
financial flexibility and expect to increase it from return generated
on capital invested, working capital reduction efforts and supply chain
optimization. This will allow us to pursue our growth initiatives and
return value to our shareholders, as we did in the past."
Dividend on common shares and normal course issuer bid
The Board of Directors of Cascades declared a quarterly dividend of
$0.04 per share to be paid on March 23, 2012 to shareholders of record
at the close of business on March 9, 2012. This dividend paid by
Cascades is an "eligible dividend" as per the Income Tax Act (Bill
C-28, Canada).
In 2011, Cascades purchased for cancellation 2,057,563 shares at an
average price of $5.22 representing an aggregate amount of
approximately $10.8 million.
Transition toInternational Financial Reporting Standards (IFRS)
All financial information, including comparative figures pertaining to
Cascades' 2010 results, has been prepared in accordance with
International Financial Reporting Standards (IFRS). Until December 31,
2010, the Corporation prepared its consolidated financial statements
and interim financial statements in accordance with Canadian generally
accepted accounting principles (GAAP). Comparative figures presented
pertaining to Cascades' 2010 results have been restated to be in
accordance with IFRS. A reconciliation of certain comparative figures
from previous GAAP to IFRS is provided in the Fourth Quarter results
investor presentation. For further details, please refer to the
investor presentation on the impact of adoption of IFRS, the fourth
quarter 2011 report and the 2010 annual report. These documents are
available at www.cascades.com/investors.
Supplemental information on non-IFRS measures
Operating income before depreciation and amortization, earnings before
interests, taxes, depreciation and amortization, operating income and
cash flow from operations are not measures of performance under IFRS.
The Corporation includes operating income before depreciation and
amortization, earnings before interests, taxes, depreciation and
amortization, operating income and cash flow from operations because
they are measures used by management to assess the operating and
financial performance of the Corporation's operating segments.
Additionally, the Corporation believes that these items provide
additional measures often used by investors to assess a corporation's
operating performance and its ability to meet debt service
requirements. However, operating income before depreciation and
amortization, earnings before interests, taxes, depreciation and
amortization, operating income and cash flow from operations do not
represent, and should not be used as a substitute for net earnings or
cash flows from operating activities as determined in accordance with
IFRS, and they are not necessarily an indication of whether cash flow
will be sufficient to fund our cash requirements. In addition, our
definition of operating income before depreciation and amortization,
earnings before interests, taxes, depreciation and amortization,
operating income and cash flow from operations may differ from those of
other companies. Cash flow from operations is defined as cash flow from
operating activities as determined in accordance with IFRS excluding
the change in working capital components.
Operating income before depreciation and amortization excluding specific
items, earnings before interests, taxes, depreciation and amortization
excluding specific items, operating income excluding specific items,
net earnings excluding specific items, net earnings per common share
excluding specific items and cash flow from operations excluding
specific items are non-IFRS measures. The Corporation believes that it
is useful for investors to be aware of specific items that have
adversely or positively affected its IFRS measures, and that the above
mentioned non-IFRS measures provide investors with a measure of
performance with which to compare its results between periods without
regard to these specific items. The Corporation's measures excluding
specific items have no standardized meaning prescribed by IFRS and are
not necessarily comparable to similar measures presented by other
companies and therefore should not be considered in isolation.
Specific items are defined to include charges for impairment of assets,
charges for facility or machine closures, debt restructuring charges,
gains or losses on sale of business unit, unrealized gains or losses on
derivative financial instruments that do not qualify for hedge
accounting, foreign exchange gains or losses on long-term debt and
other significant items of an unusual or non-recurring nature.
Net earnings (loss), which is a performance measure defined by IFRS is
reconciled below to operating income, operating income excluding
specific items and operating income before depreciation excluding
specific items or earnings before interests, taxes, depreciation and
amortization excluding specific items:
|
|
|
|
|
|
(in millions of Canadian dollars)
| 2011 |
2010
|
| Q4/2011 |
Q4/2010
|
Q3/2011
|
|
|
| Net earnings (loss) | 99 |
41
| | 5 |
(12)
|
(20)
|
|
Net loss (earnings) from discontinued operations
| (114) |
(21)
|
| (1) |
(1)
|
2
|
|
Non-controlling interest
| (3) |
2
|
| - |
1
|
(3)
|
|
Share of results of associates and joint ventures
| (14) |
(27)
|
| (3) |
(4)
|
(1)
|
|
Provision for (recovery of) income taxes
| (56) |
(6)
|
| (31) |
(8)
|
10
|
|
Foreign exchange loss (gain) on long-term debt and financial instruments
| (4) |
4
|
| (9) |
5
|
(5)
|
|
Loss on long-term debt refinancing
| - |
3
|
| - |
-
|
-
|
|
Financing expense
| 100 |
107
|
| 25 |
26
|
24
|
|
|
| Operating income (loss) | 8 |
103
| | (14) |
7
|
7
|
|
Specific items :
|
|
|
|
|
|
|
|
Loss (gain) on disposal and others
| (48) |
15
|
| (38) |
-
|
-
|
|
Inventory adjustment resulting from business acquisition
| 10 |
-
|
| 4 |
-
|
-
|
|
Net impairment loss
| 59 |
29
|
| 44 |
28
|
14
|
|
Closure and restructuring costs
| 8 |
1
|
| 3 |
-
|
1
|
|
Unrealized loss (gain) on financial instruments
| 12 |
7
|
| 1 |
(1)
|
11
|
|
| 41 |
52
|
| 14 |
27
|
26
|
|
|
| Operating income - excluding specific items | 49 |
155
| | - |
34
|
33
|
|
Depreciation and amortization
| 180 |
155
|
| 51 |
38
|
46
|
| Operating income before depreciation and amortization - excluding
specific items | 229 |
310
| | 51 |
72
|
79
|
The following table reconciles net earnings (loss) and net earnings
(loss) per share to net earnings excluding specific items and net
earnings per share excluding specific items:
|
|
|
|
|
|
(in millions of Canadian dollars, except amounts per share)
| Net earnings (loss) | | Net earnings (loss) per share1 |
|
| 2011 |
2010
|
| Q4/2011 |
Q4/2010
|
Q3/2011
| | 2011 |
2010
| | Q4/2011 |
Q4/2010
|
Q3/2011
|
|
|
| As per IFRS | 99 |
41
| | 5 |
(12)
|
(20)
|
| $1.03 |
$0.43
|
| $0.05 |
$(0.12)
|
$(0.21)
|
|
Specific items :
|
|
|
Inventory adjustment resulting from business acquisition
| 10 |
-
|
| 4 |
-
|
-
|
| $0.08 |
$ -
|
| $0.04 |
$ -
|
$ -
|
|
Loss (gain) on disposal and others
| (48) |
15
|
| (38) |
-
|
-
|
| $(0.55) |
$0.12
|
| $(0.40) |
$ -
|
$ -
|
|
Net impairment loss
| 59 |
29
|
| 44 |
28
|
14
|
| $0.45 |
$0.20
|
| $0.34 |
$0.19
|
$0.10
|
|
Closure and restructuring costs
| 8 |
1
|
| 3 |
-
|
1
|
| $0.06 |
$0.01
|
| $0.02 |
$ -
|
$0.01
|
|
Unrealized loss (gain) on financial instruments
| 12 |
7
|
| 1 |
(1)
|
11
|
| $0.11 |
$0.07
|
| $0.01 |
$(0.01)
|
$0.10
|
|
Loss on long-term debt refinancing
| - |
3
|
| - |
-
|
-
|
| $ - |
$0.02
|
| $ - |
$ -
|
$ -
|
|
Foreign exchange loss (gain) on long-term debt and financial instruments
| (4) |
4
|
| (9) |
5
|
(5)
|
| $(0.04) |
$0.03
|
| $(0.08) |
$0.04
|
$(0.05)
|
|
Share of results of significantly influenced companies and
non-controlling interest
| (3) |
(10)
|
| (2) |
1
|
1
|
| $(0.03) |
$(0.11)
|
| $(0.02) |
$0.01
|
$0.01
|
|
Included in discontinued operations, net of tax
| (108) |
8
|
| (1) |
8
|
2
|
| $(1.13) |
$0.06
|
| $ - |
$0.06
|
$0.02
|
|
Tax effect on specific items and other tax adjustments¹
| (39) |
(18)
|
| (11) |
(12)
|
(6)
|
| $(0.12) |
$ -
|
| $ - |
$ -
|
$ -
|
|
| (113) |
39
|
| (9) |
29
|
18
|
| $(1.17) |
$0.40
|
| $(0.09) |
$0.29
|
$0.19
|
| Excluding specific items | (14) |
80
| | (4) |
17
|
(2)
|
| $(0.14) |
$0.83
|
| $(0.04) |
$0.17
|
$(0.02)
|
|
¹
|
Specifc amounts per share are calculated on an after-tax basis. Per
share amounts of line item ''Tax effect on specific items and other tax
adjustments'' only includes the effect of tax adjustments.
|
The following table reconciles cash flow provided by operating
activities to cash flow (adjusted) from operations excluding specific
items:
|
|
|
|
| Cash flow from operations |
|
(in millions of Canadian dollars)
| 2011 |
2010
|
| Q4/2011 |
Q4/2010
|
Q3/2011
|
|
|
| Cash flow provided by (used from) operating activities | 104 |
170
| | 102 |
88
|
41
|
|
Changes in non-cash working capital components
| 22 |
23
|
| (67) |
(47)
|
19
|
| Cash flow (adjusted) from operations | 126 |
193
| | 35 |
41
|
60
|
|
Specific items, net of current income taxes :
|
|
|
|
|
Loss on long-term debt refinancing
| - |
3
|
| - |
-
|
-
|
|
Closure and restructuring costs
| 7 |
1
|
| 5 |
-
|
1
|
| Excluding specific items | 133 |
197
| | 40 |
41
|
61
|
Founded in 1964, Cascades produces, converts and markets packaging and
tissue products composed mainly of recycled fibres. The Company employs
close to 11,000 men and women in close to a 100 units located in North
America and Europe. Its management philosophy, its more than 45 years
of experience in recycling and its continued efforts in research and
development are strengths which enable Cascades to create new products
for its customers. Cascades' shares trade on the Toronto Stock
Exchange, under the ticker symbol CAS.
Certain statements in this release, including statements regarding
future results and performance, are forward-looking statements (as such
term is defined under the Private Securities Litigation Reform Act of
1995) based on current expectations. The accuracy of such statements is
subject to a number of risks, uncertainties and assumptions that may
cause actual results to differ materially from those projected,
including, but not limited to, the effect of general economic
conditions, decreases in demand for the Company's products, increases
in raw material costs, fluctuations in selling prices and adverse
changes in general market and industry conditions and other factors
listed in the Company's Securities and Exchange Commission filings.
Consolidated Balance Sheets
|
(unaudited)
|
|
|
(in millions of Canadian dollars)
| December 31, 2011 |
December 31,
2010
|
January 1,
2010
|
| Assets |
|
| Current assets |
|
|
Cash and cash equivalents
| 12 |
6
|
8
|
|
Accounts receivable
| 556 |
490
|
456
|
|
Current income tax assets
| 24 |
21
|
13
|
|
Inventories
| 516 |
476
|
467
|
|
Financial assets
| 6 |
12
|
14
|
|
Assets of disposal group held for sale
| 12 |
-
|
-
|
|
| 1,126 |
1,005
|
958
|
| Long-term assets |
|
|
Investments in associates and joint ventures
| 221 |
262
|
260
|
|
Property, plant and equipment
| 1,703 |
1,553
|
1,637
|
|
Intangible assets
| 189 |
126
|
137
|
|
Financial assets
| 25 |
4
|
7
|
|
Other assets
| 86 |
92
|
73
|
|
Deferred income tax assets
| 57 |
82
|
74
|
|
Goodwill and other intangible assets with infinite useful life
| 324 |
313
|
315
|
|
| 3,731 |
3,437
|
3,461
|
| Liabilities and Shareholders' Equity |
|
| Current liabilities |
|
|
Bank loans and advances
| 90 |
42
|
50
|
|
Accounts payable and accrued liabilities
| 539 |
440
|
395
|
|
Current income tax liabilities
| 2 |
2
|
1
|
|
Provisions for contingencies and charges
| 26 |
23
|
24
|
|
Current portion of financial liabilities and other liabilities
| 20 |
14
|
7
|
|
Current portion of long-term debt
| 49 |
7
|
6
|
|
Revolving credit facility, renewed in 2011
| - |
394
|
-
|
|
| 726 |
922
|
483
|
| Long-term liabilities |
|
|
Long-term debt
| 1,358 |
960
|
1,423
|
|
Provisions for contingencies and charges
| 33 |
37
|
31
|
|
Financial liabilities
| 111 |
83
|
54
|
|
Other liabilities
| 249 |
196
|
166
|
|
Deferred income tax liabilities
| 89 |
167
|
192
|
|
| 2,566 |
2,365
|
2,349
|
|
|
|
| Equity attributable to Shareholders |
|
|
Capital stock
| 486 |
496
|
499
|
|
Contributed surplus
| 14 |
14
|
14
|
|
Retained earnings
| 615 |
576
|
575
|
|
Accumulated other comprehensive income (loss)
| (86) |
(37)
|
3
|
|
| 1,029 |
1,049
|
1,091
|
|
Non-controlling interest
| 136 |
23
|
21
|
| Total equity | 1,165 |
1,072
|
1,112
|
|
| 3,731 |
3,437
|
3,461
|
Consolidated Statements of Earnings
|
(unaudited)
|
|
|
|
|
| For the 3-month periods ended December 31 | For the years ended December 31 |
|
(in millions of Canadian dollars, except per share amounts and number of
shares)
| 2011 |
2010
| 2011 |
2010
|
| Sales | 913 |
783
| 3,625 |
3,182
|
| Cost of sales and expenses |
|
|
|
|
|
Cost of sales (including depreciation and amortization of $51 million;
$38 million; $180 million and $155 million)
| 819 |
673
| 3,247 |
2,702
|
|
Selling and administrative expenses
| 96 |
79
| 362 |
325
|
|
Loss (gain) on disposal and others
| (38) |
-
| (48) |
15
|
|
Net impairment loss and other restructuring costs
| 47 |
29
| 67 |
31
|
|
Foreign exchange loss (gain)
| 2 |
3
| (19) |
7
|
|
Loss (gain) on financial instruments
| 1 |
(8)
| 8 |
(1)
|
|
| 927 |
776
| 3,617 |
3,079
|
| Operating income (loss) | (14) |
7
| 8 |
103
|
|
Financing expense
| 25 |
26
| 100 |
107
|
|
Loss on refinancing of long-term debt
| - |
-
| - |
3
|
|
Foreign exchange loss (gain) on long-term debt and financial instruments
| (9) |
5
| (4) |
4
|
| Loss before income taxes | (30) |
(24)
| (88) |
(11)
|
| Recovery of income taxes | (31) |
(8)
| (56) |
(6)
|
| Share of results of associates and joint ventures | (3) |
(4)
| (14) |
(27)
|
| Net earnings (loss) from continuing operations including non-controlling
interest | 4 |
(12)
| (18) |
22
|
| Net earnings from discontinued operations | 1 |
1
| 114 |
21
|
| Net earnings (loss) including non-controlling interest | 5 |
(11)
| 96 |
43
|
| Less: non-controlling interest | - |
1
| (3) |
2
|
| Net earnings (loss) attributable to Shareholders | 5 |
(12)
| 99 |
41
|
|
|
|
|
|
|
| Net earnings (loss) from continuing operations per common share |
|
|
|
|
|
|
Basic
| 0.04 |
(0.14)
| ($0.16) |
$0.21
|
|
|
Diluted
| 0.04 |
(0.14)
| ($0.16) |
$0.21
|
| Net earnings (loss) per common share |
|
|
|
|
|
|
Basic
| 0.05 |
(0.12)
| $1.03 |
$0.43
|
|
|
Diluted
| 0.05 |
(0.12)
| $1.02 |
$0.42
|
| Weighted average basic number of common shares outstanding | 95,108,991 |
96,608,106
| 96,013,220 |
96,807,032
|
|
|
|
|
|
|
| Net earnings (loss) attributable to Shareholders: |
|
|
|
|
|
|
|
|
|
|
|
| Continuing operations | 4 |
(13)
| (15) |
20
|
|
| Discontinued operations | 1 |
1
| 114 |
21
|
| Net earnings (loss) | 5 |
(12)
| 99 |
41
|
Consolidated Statements of Comprehensive Income (Loss)
|
(unaudited)
|
|
|
|
| For the 3-month periods ended December 31 | For the years ended December 31 |
|
(in millions of Canadian dollars)
| 2011 |
2010
| 2011 |
2010
|
| Net earnings (loss) including non-controlling interest for the period | 5 |
(11)
| 96 |
43
|
| Other comprehensive income (loss) |
|
|
| Translation adjustments |
|
|
|
|
Change in foreign currency translation of foreign subsidiaries
| (35) |
(31)
| (28) |
(49)
|
|
|
|
Change in foreign currency translation related to net investment
hedging activities
| 20 |
19
| 6 |
28
|
|
|
|
Income taxes
| (3) |
(2)
| (1) |
(4)
|
|
| Cash flow hedges |
|
|
|
|
|
|
|
Change in fair value of foreign exchange forward contracts
| (6) |
-
| (11) |
1
|
|
|
|
Change in fair value of interest rate swap agreements
| (15) |
3
| (23) |
-
|
|
|
|
Change in fair value of commodity derivative financial instruments
| (10) |
(2)
| (11) |
(23)
|
|
|
|
Income taxes
| 12 |
1
| 14 |
8
|
|
| Actuarial loss on post-employment benefit obligations
|
|
|
|
|
|
|
|
Change in fair value
| (13) |
(34)
| (66) |
(34)
|
|
|
|
Income taxes
| 3 |
10
| 17 |
10
|
|
| Available-for-sale financial assets |
|
|
|
|
Change in fair value
| -
|
(1)
| -
|
(1)
|
|
|
|
| (47) |
(37)
| (103) |
(64)
|
| Comprehensive income (loss) including non-controlling interest for the period | (42) |
(48)
| (7) |
(21)
|
| Less: Comprehensive income (loss) attributable to non-controlling
interest for the period | (5) |
1
| (8) |
2
|
| Comprehensive income (loss) attributable to Shareholders for the period | (37) |
(49)
| 1 |
(23)
|
|
|
|
|
|
|
| Comprehensive income (loss) attributable to Shareholders: |
|
|
|
|
|
|
|
|
|
|
|
| Continuing operations | (38) |
(50)
| (113) |
(44)
|
|
| Discontinued operations | 1 |
1
| 114 |
21
|
| Comprehensive income (loss) | (37) |
(49)
| 1 |
(23)
|
Consolidated Statements of Equity
|
|
|
|
(unaudited)
| For the year ended December 31, 2011 |
|
(in millions of Canadian dollars)
|
Capital
stock
|
Contributed
surplus
|
Retained
earnings
|
Accumulated
other
comprehensive
income (loss)
|
Total equity
attributable to
Shareholders
|
Non-
controlling
interest
|
Total
equity
|
| Balance - Beginning of year | 496 | 14 | 576 | (37) | 1,049 | 23 | 1,072 |
|
|
Net earnings for the year
| - | - | 99 | - | 99 | (3) | 96 |
|
|
Business acquisitions
| - | - | - | - | - | 129 | 129 |
|
|
Other comprehensive loss
| - | - | (49) | (49) | (98) | (5) | (103) |
|
|
Dividends
| - | - | (15) | - | (15) | - | (15) |
|
|
Stock options
| 1 | - | - | - | 1 | - | 1 |
|
|
Redemption of common shares
| (11) | - | - | - | (11) | - | (11) |
|
|
Acquisition of non-controlling interest
| - | - | 4 | - | 4 | (7) | (3) |
|
|
Dividend paid to non-controlling interest
| - | - | - | - | - | (1) | (1) |
| Balance - End of year | 486 | 14 | 615 | (86) | 1,029 | 136 | 1,165 |
|
|
|
|
|
For the year ended December 31, 2010
|
|
(in millions of Canadian dollars)
|
Capital
stock
|
Contributed
surplus
|
Retained
earnings
|
Accumulated
other
comprehensive
income (loss)
|
Total equity
attributable to
Shareholders
|
Non-
controlling
interest
|
Total
equity
|
| Balance - Beginning of year |
499
|
14
|
575
|
3
|
1,091
|
21
|
1,112
|
|
|
Net earnings for the year
|
-
|
-
|
41
|
-
|
41
|
2
|
43
|
|
|
Other comprehensive loss
|
-
|
-
|
(24)
|
(40)
|
(64)
|
-
|
(64)
|
|
|
Dividends
|
-
|
-
|
(16)
|
-
|
(16)
|
-
|
(16)
|
|
|
Stock options
|
-
|
1
|
-
|
-
|
1
|
-
|
1
|
|
|
Redemption of common shares
|
(3)
|
(1)
|
-
|
-
|
(4)
|
-
|
(4)
|
| Balance - End of year |
496
|
14
|
576
|
(37)
|
1,049
|
23
|
1,072
|
Consolidated Statements of Cash Flows
|
(unaudited)
|
|
|
|
(in millions of Canadian dollars)
| For the 3-month periods endedDecember 31 | For the years ended December 31 |
|
| 2011 |
2010
| 2011 |
2010
|
| Operating activities from continuing operations |
|
|
|
|
|
Net earnings (loss) attributable to Shareholders for the year
| 5 |
(12)
| 99 |
41
|
|
Net earnings from discontinued operations for the year
| (1) |
(1)
| (114) |
(21)
|
|
Net earnings (loss) from continuing operations
| 4 |
(13)
| (15) |
20
|
|
Adjustments for
|
|
|
|
|
|
|
Financing expense
| 25 |
26
| 100 |
107
|
|
|
Depreciation and amortization
| 51 |
38
| 180 |
155
|
|
|
Loss (gain) on disposal and others
| (37) |
(29)
| (48) |
(14)
|
|
|
Net impairment loss and other restructuring costs
| 42 |
44
| 60 |
45
|
|
|
Unrealized loss (gain) on financial instruments
| 1 |
(1)
| 12 |
7
|
|
|
Foreign exchange loss (gain) on long-term debt and financial instruments
| (9) |
5
| (4) |
4
|
|
|
Recovery of income taxes
| (31) |
(8)
| (56) |
(6)
|
|
|
Share of results of associates and joint ventures
| (3) |
(4)
| (14) |
(27)
|
|
|
Non-controlling interest
| - |
1
| (3) |
2
|
|
|
Net financing expense paid
| (33) |
(32)
| (97) |
(94)
|
|
|
Income tax paid
| 11 |
(6)
| (2) |
(16)
|
|
|
Dividend received
| 16 |
16
| 16 |
16
|
|
|
Others
| (2) |
4
| (3) |
(6)
|
|
| 35 |
41
| 126 |
193
|
|
Changes in non-cash working capital components
| 67 |
47
| (22) |
(23)
|
|
| 102 |
88
| 104 |
170
|
| Investing activities from continuing operations |
|
|
|
|
|
Purchase of investment in associates and joint ventures
| (20) |
(2)
| (65) |
(8)
|
|
Purchases of property, plant and equipment
| (51) |
(42)
| (141) |
(118)
|
|
Disposals of property, plant and equipment
| 22 |
-
| 32 |
7
|
|
Change in other assets
| (6) |
(8)
| 1 |
(29)
|
|
Business acquisitions, net of cash acquired
| (56) |
-
| (60) |
(3)
|
|
Proceeds on disposal of business, net of cash disposed
| (2) |
-
| 4 |
-
|
|
| (113) |
(52)
| (229) |
(151)
|
| Financing activities from continuing operations |
|
|
|
|
|
Bank loans and advances
| (25) |
(12)
| 4 |
(7)
|
|
Change in revolving credit facilities
| 146 |
68
| (120) |
243
|
|
Purchase of senior notes
| - |
-
| - |
(165)
|
|
Increase in other long-term debt
| 2 |
1
| 3 |
1
|
|
Payments of other long-term debt
| (13) |
(102)
| (26) |
(107)
|
|
Redemption of common shares
| (3) |
-
| (11) |
(4)
|
|
Acquisition and dividend paid to non-controlling interest
| (2) |
-
| (4) |
-
|
|
Dividend paid to Corporation's Shareholders
| (3) |
(4)
| (15) |
(16)
|
|
| 102 |
(49)
| (169) |
(55)
|
| Change in cash and cash equivalents during the period from continuing operations | 91 |
(13)
| (294) |
(36)
|
| Change in cash and cash equivalents from discontinued operations,
including proceeds on disposal during the period | (92) |
5
| 298 |
35
|
| Net change in cash and cash equivalents during the period | (1) |
(8)
| 4 |
(1)
|
| Currency translation on cash and cash equivalent | 2 |
(1)
| 2 |
(1)
|
| Cash and cash equivalents—Beginning of period | 11 |
15
| 6 |
8
|
| Cash and cash equivalents—End of period | 12 |
6
| 12 |
6
|
Segmented Information
The Corporation analyzes the performance of its operating segments based
on their operating income before depreciation and amortization, which
is not a measure of performance under International Financial Reporting
Standards; however, the chief operating decision-maker ("CODM") uses
this performance measure for assessing the operating performance of
each reportable segment. Earnings for each segment are prepared on the
same basis as those of the Corporation. Intersegment operations are
recorded on the same basis as sales to third parties, which are at fair
market value.
The Corporation's operating segments are reported in a manner consistent
with the internal reporting provided to the CODM. The Chief Executive
Officer has authority for resource allocation and assessment of the
Corporation's performance and is therefore the CODM.
In 2011, the Corporation has modified its segmented information
disclosure. Containerboard manufacturing and converting activities are
now presented on a consolidated basis. As well, North American
manufacturing and converting boxboard activities are also presented
consolidated basis while European activities are still reported as a
separate sub-sector. The Corporation also changed the presentation for
its specialty products, in order to reflect how management analyzes its
financial information. The Corporation has reclassified comparative
figures to conform to the presentation adopted.
The Corporation's operations are managed in four segments: North
American and European boxboard, containerboard, specialty products
(which consist of the packaging products of the Corporation) and tissue
papers.
Sales of the Corporation by reportable segment are as follows:
|
|
|
|
|
|
| SALES |
|
(unaudited)
|
| For the 3-month periods ended December 31 | For the yearsended December31 |
|
(in millions of Canadian dollars)
|
| 2011 |
2010
| 2011 |
2010
|
| Packaging products |
|
|
|
|
|
|
| Boxboard |
|
|
|
|
|
|
|
|
North America
|
| 67 |
206
| 466 |
846
|
|
|
|
Europe
|
| 206 |
56
| 745 |
208
|
|
|
|
Discontinued operations of North America
|
| - |
(120)
| (148) |
(470)
|
|
|
| 273 |
142
| 1,063 |
584
|
|
| Containerboard |
| 233 |
268
| 979 |
1,086
|
|
| Specialty Products |
| 206 |
201
| 851 |
786
|
|
|
Intersegment sales
|
| (24) |
(29)
| (109) |
(106)
|
|
|
| 688 |
582
| 2,784 |
2,350
|
| Tissue papers |
| 233 |
212
| 871 |
853
|
|
Intersegment sales and others
|
| (8) |
(11)
| (30) |
(21)
|
| Total |
| 913 |
783
| 3,625 |
3,182
|
The operating income (loss) before depreciation and amortization of the
Corporation by reportable segment are as follows:
|
|
|
|
|
|
| OPERATING INCOME (LOSS) BEFORE DEPRECIATION AND AMORTIZATION |
|
(unaudited)
| For the 3-month periods ended December 31 | For the years ended December 31 |
|
(in millions of Canadian dollars)
| 2011 |
2010
| 2011 |
2010
|
| Packaging products |
|
|
|
|
|
| Boxboard |
|
|
|
|
|
|
|
North America
| (8) |
9
| (8) |
63
|
|
|
|
Europe
| 8 |
4
| 46 |
8
|
|
|
|
Discontinued operations of North America
| - |
(16)
| (12) |
(59)
|
|
| - |
(3)
| 26 |
12
|
|
| Containerboard | - |
22
| 61 |
144
|
|
| Specialty products | (10) |
12
| 16 |
63
|
|
| (10) |
31
| 103 |
219
|
|
| Tissue papers | 50 |
17
| 93 |
84
|
| Corporate | (3) |
(3)
| (8) |
(45)
|
| Operating income before depreciation and amortization | 37 |
45
| 188 |
258
|
|
|
|
|
|
|
|
Depreciation and amortization
| (51) |
(38)
| (180) |
(155)
|
|
Financing expense
| (25) |
(26)
| (100) |
(107)
|
|
Loss on refinancing of long term debt
| - |
-
| - |
(3)
|
|
Foreign exchange gain (loss) on long term debt and financial instruments
| 9 |
(5)
| 4 |
(4)
|
|
|
|
|
|
|
| Loss before income taxes | (30) |
(24)
| (88) |
(11)
|
Purchases of property, plant and equipment by the Corporation by
reportable segment are as follows:
|
|
|
|
|
|
|
|
| PURCHASES OF PROPERTY, PLANT AND EQUIPMENT |
|
| For the 3-month periods ended December 31 | For the years ended December 31 |
|
(in millions of Canadian dollars)
| 2011 |
2010
| 2011 |
2010
|
| Packaging products |
|
|
|
|
|
| Boxboard |
|
|
|
|
|
|
|
North America
| 5 |
8
| 13 |
21
|
|
|
|
Europe
| 9 |
2
| 30 |
5
|
|
|
|
Discontinued operations of North America
| - |
(5)
| (1) |
(13)
|
|
| 14 |
5
| 42 |
13
|
|
| Containerboard | 18 |
9
| 42 |
31
|
|
| Specialty products | 9 |
18
| 24 |
30
|
|
| 41 |
32
| 108 |
74
|
|
|
|
|
|
|
| Tissue papers | 14 |
14
| 31 |
36
|
| Corporate | 5 |
2
| 9 |
17
|
| Total purchases | 60 |
48
| 148 |
127
|
|
Disposal of property, plant and equipment
| (22) |
-
| (32) |
(7)
|
|
Acquisition under capital-lease agreement
| - |
-
| - |
(4)
|
|
| 38 |
48
| 116 |
116
|
|
Purchases of property, plant and equipment included in accounts payable
|
|
|
|
|
|
|
Beginning of year
| 16 |
14
| 18 |
13
|
|
|
End of year
| (25) |
(20)
| (25) |
(18)
|
| Purchases of property, plant and equipment | 29 |
42
| 109 |
111
|